Companies similar to LEXEO THERAPEUTICS INC (LXEO)
Health Care · NASDAQ
LEXEO THERAPEUTICS INC (LXEO)'s closest peers include ROCKET PHARMACEUTICALS INC (RCKT), BEAM THERAPEUTICS INC (BEAM), EDITAS MEDICINE INC (EDIT), INTELLIA THERAPEUTICS INC (NTLA) and Sarepta Therapeutics (SRPT). This peer set is drawn from LXEO's enriched company profile and is informational only — not financial advice.
Similar companies
-
ROCKET PHARMACEUTICALS INCRCKTHealth Care
Rocket Pharmaceuticals is a clinical-stage biotechnology company developing transformative gene therapies for rare, high-unmet-need genetic disorders.
$3.40 (as of 2026-07-21) · market cap $368M
-
BEAM THERAPEUTICS INCBEAMHealth Care
Beam Therapeutics is developing base editing medicines—a precision genetic cure approach—for serious inherited diseases like sickle cell disease and rare…
$27.29 (as of 2026-07-21) · market cap $2.8B
-
EDITAS MEDICINE INCEDITHealth Care
A pioneering CRISPR gene editing company developing in vivo therapies for genetic diseases, with lead candidate EDIT-401 targeting hyperlipidemia through LDL…
$2.89 (as of 2026-07-21) · market cap $443M
-
INTELLIA THERAPEUTICS INCNTLAHealth Care
CRISPR-based genome editing company developing in vivo therapies for rare genetic diseases including hereditary angioedema and ATTR amyloidosis.
$11.47 (as of 2026-07-21) · market cap $1.6B
-
Sarepta TherapeuticsSRPTHealth Care
A biopharmaceutical leader in genetic medicine, specializing in innovative RNA-targeted therapies and gene treatments for Duchenne muscular dystrophy and rare…
$16.21 (as of 2026-07-21) · market cap $1.8B
Not quite? Describe exactly what you want →
Peers are drawn from LXEO's enriched profile (the same similarity signal the chat uses for "companies like LXEO"). See the full profile: LEXEO THERAPEUTICS INC (LXEO).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.